- All sections
- C - Chemistry; metallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/6524 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
Patent holdings for IPC class C07F 9/6524
Total number of patents in this class: 77
10-year publication summary
|
5
|
8
|
8
|
7
|
8
|
3
|
11
|
9
|
7
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cancer Targeted Technology LLC | 25 |
9 |
| Wisconsin Alumni Research Foundation | 3820 |
7 |
| Ventana Medical Systems, Inc. | 1003 |
4 |
| Bristol-myers Squibb Company | 4863 |
3 |
| Astex Therapeutics Limited | 250 |
3 |
| Ustav Organicke Chemie a Biochemie AV CR, V.v.i. | 118 |
3 |
| Mycovia Pharmaceuticals, Inc. | 41 |
3 |
| Centre National de La Recherche Scientifique | 10102 |
2 |
| Sumitomo Chemical Company, Limited | 8988 |
2 |
| Bracco Imaging S.p.A. | 315 |
2 |
| European Molecular Biology Laboratory | 310 |
2 |
| Five Eleven Pharma Inc. | 18 |
2 |
| Nagasaki University | 197 |
2 |
| Universite de Bretagne Occidentale | 110 |
2 |
| Auspherix Limited | 8 |
2 |
| The Affiliated Hospital of Southwest Medical University | 8 |
2 |
| Veraxa Biotech GmbH | 10 |
2 |
| Siemens AG | 24565 |
1 |
| The Regents of the University of California | 19517 |
1 |
| Bayer Schering Pharma AG | 429 |
1 |
| Other owners | 22 |